ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,243Medicare Part D Prescriptions Filled, Including Refills

Rank: 647 out of 3593

$484K Total Retail Price of All Prescriptions

Rank: 667 out of 3593

845 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 845 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

32% of this provider’s 845 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 4,352 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 1,045 478 S3 1 7
ZOLPIDEM TARTRATE 424 220 2 12
LISINOPRIL 398 168 3 2
OMEPRAZOLE 272 112 4 5
SIMVASTATIN 269 161 5 1
AMLODIPINE BESYLATE 263 171 6 3
LEVOTHYROXINE SODIUM 252 148 7 4
METFORMIN HCL 181 107 8 6
HYDROCHLOROTHIAZIDE 180 113 9 10
CARISOPRODOL 144 14 R 10 97
PROAIR HFA 115 39 11 54
CRESTOR 114 73 12 21
FUROSEMIDE 110 65 13 9
TRAMADOL HCL 110 65 13 17
METOPROLOL SUCCINATE 103 55 15 19
SUBOXONE 99 0 16 275
OXYCODONE HCL-ACETAMINOPHEN 96 32 S2 17 82
ALPRAZOLAM 95 19 18 37
GABAPENTIN 87 33 19 16
TRAZODONE HCL 84 31 20 53
LYRICA 79 35 21 105
CARVEDILOL 79 44 21 23
LOSARTAN POTASSIUM 77 60 23 14
METOPROLOL TARTRATE 77 56 23 8
CYCLOBENZAPRINE HCL 72 0 R 25 72
ATENOLOL 72 29 25 11
ETODOLAC 69 25 27 247
NEXIUM 69 32 27 36
IBUPROFEN 69 30 27 43
CLOPIDOGREL 66 47 30 30
CITALOPRAM HBR 61 21 31 25
FLUTICASONE PROPIONATE 61 34 31 32
CLONIDINE HCL 60 23 33 41
PRAVASTATIN SODIUM 59 34 34 13
JANUVIA 58 39 35 81
SERTRALINE HCL 57 32 36 28
AZITHROMYCIN 54 20 37 34
POTASSIUM CHLORIDE 54 30 37 24
TESTOSTERONE CYPIONATE 52 14 S3 39 289
PLAVIX 51 34 40 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.